Table 2.
Name of Substances/Compound | Dose | Model | Observations | Reference |
---|---|---|---|---|
(−)—Epicatechin | 50 and 100 mg/kg for 2 weeks | Unmodified rat serum albumin and AGE-modified rat serum albumin intravenous injected (normoglycemic) rats | ↑ AGE breaking activity | [62] |
↓ AGE burden and vascular apoptosis | ||||
10, 25, 50, 100, 250, 500 and 1000 μg/mL | Collagen–glycated bovine serum albumin complexes and glycated human serum albumin | ↑ AGE breaking activity | ||
Epigallocatechin | 2, 20 and 200 µg | Balb/c mice intradermally injected with NPDR patients serum | ↓ angiogenic effects | [63] |
Green tea | 5.7 g/kg for 12 weeks | STZ-induced T1DM rats | ↓ occludin, NMDAr1 subunit and GLAST levels | [65] |
↓ BRB breakdown | ||||
↓ impaired electroretinography recordings | ||||
↓ GFAP, oxidative retinal markers and glutamine synthetase levels | ||||
1, 10 or 100 µg/mL | High glucose-exposed PRRMC, rMC-1 and ARPE-19 cells | ↑ GSH, GLAST and NMDAR1 protein levels | ||
↓ ROS and glutamine synthetase | ||||
↓ claudin-1 levels | ||||
100 mL for 12 months | STZ-induced T1DM rats | ↓ superoxide production, acellular capillaries and pericyte ghosts | [66] | |
Epigallocatechin gallate | 2, 20 and 200 µg/mL | Balb/c mice intradermally injected with NPDR patients serum | ↓ angiogenic effects | [63] |
200 mg/kg orally administered for 4 days | VEGF intradermally injected Balb/c mice and Sprague-Dawley rats | ↓ vascular leakage and permeability by BRB breakdown | [67] | |
1, 10, 25 and 50 μM for 1.5, 24 or 72 h | TPA and TNF-α-exposed HRPECs and ARPE-19 cells | ↓ MMP-9 levels | ||
↓ cell death and MMP-9, VEGF and VEGF Receptor-2 mRNA expression | ||||
H2O2-exposed ARPE-19 cells | ||||
↓ ROS levels | ||||
VEGF-exposed HRMECs | ↓ cell proliferation, vascular permeability and tube formation | |||
Catechin | 50, 100 and 200 mg/kg by intravitreal injection for 8 weeks | STZ-induced diabetic rats | ↑ HSP27 levels | [68] |
↓ IL-1β, IL-6 and TNF-α levels | ||||
↓ NF-κB pathway |
AGE: advanced glycation end products, ARPE-19: human retinal pigment epithelial cell line, Balb/c: Bagg’s albino C mice substrain, BRB: blood–retinal barrier, GFAP: glial fibrillary acidic protein, GLAST: glutamate aspartate transporter 1, GSH: glutathione, H2O2: hydrogen peroxide, HRMECs: human retinal microvascular endothelial cells, HRPECs: human retinal pigment epithelial cells, HSP27: heat shock protein 27, IL-1β: interleukin-1β, IL-6: interleukin-6, MMP-9: metalloproteinase-9, NF-κB: nuclear factor kappa-B, NMDAr1: NR1 subunit of N-methyl-D-aspartate receptor, NPDR: non-proliferative diabetic retinopathy, PRRMC: primary rat retina Müller cells, rMC-1: transformed rat retinal Müller cell line, ROS: reactive oxygen species, STZ: streptozotocin, T1DM: type 1 diabetes mellitus, TNF-α: tumor necrosis factor alfa, TPA: 12-O-tetradecanoylphorbol-13-acetate, VEGF: vascular endothelial growth factor, ↑: increase, ↓ decrease.